Implementing recommendations for routine mismatch repair (MMR) immunohistochemistry (IHC) testing of endometrial cancer and subsequent patient management
Lynch syndrome is associated with an increased risk of cancer, including endometrial cancer. We audited the introduction of a nurse-led testing and management pathway for Lynch syndrome. All 191 patients diagnosed with endometrial cancer at Somerset NHS Foundation Trust between January 2022 and Dece...
Saved in:
Main Authors: | Jo Morrison, Mohamed Shawky, Maria Murrey |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | BMJ Open Quality |
Online Access: | https://bmjopenquality.bmj.com/content/14/1/e003014.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DNA mismatch repair (MMR) genes expression in lung cancer and its correlation with different clinicopathologic parameters
by: Mayada Saad Farrag, et al.
Published: (2025-01-01) -
Exploring Multiplex Immunohistochemistry (mIHC) Techniques and Histopathology Image Analysis: Current Practice and Potential for Clinical Incorporation
by: Aria Kaiyuan Sun, et al.
Published: (2025-01-01) -
Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing
by: Ignacio I Wistuba, et al.
Published: (2025-01-01) -
Harnessing Machine Learning and Nomogram Models to Aid in Predicting Progression-Free Survival for Gastric Cancer Patients Post-Gastrectomy with Deficient Mismatch Repair(dMMR)
by: Yifan Li, et al.
Published: (2025-01-01) -
Mismatch repair, p53, and L1 cell adhesion molecule status influence the response to chemotherapy in advanced and recurrent endometrial cancer
by: Jung Chul Kim, et al.
Published: (2024-12-01)